Intellia Therapeutics

8 followers

‌

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

John Leonard

President & CEO

John Leonard

Collapse

Eliana Clark

EVP, CTO

David Lebwohl

EVP, Chief Medical Officer

Derek Hicks

EVP, Chief Business Officer

Laura Sepp-Lorenzino

EVP, Chief Scientific Officer

Edward Dulac

EVP & CFO

Michael Dube

Vice President, Chief Accounting Officer

Marika St. Amand

SVP, Chief Human Resources Officer

James Basta

EVP, General Counsel & Corporate Secretary

Aron Stein

SVP, Regulatory Affairs

Mary Ferguson

Senior Vice President, Head of Intellectual Property

Yuanxin Xu

SVP, Early Development & Transitional Medicine

Maria Natale

SVP, Commercial

Ray Kelley

Vice President Of Financial Planning Analysis

Emily Williams

Director Corporate Communications

Teams

+38

Research and Development

41 members

+31

Leadership Team

34 members

+19

Corporate Governance and Legal

22 members

+12

Scientific and Technical Positions

15 members

Clinical Operations

11 members

Human Resources and Talent Management

7 members

Similar companies

Akebia Therapeutics

3 followers

Aldevron

2 followers

Kiniksa Pharmaceuticals

1 follower

Genentech

142 followers

Gilead Sciences

119 followers

Biogen

107 followers

Regeneron

87 followers

Vertex Pharmaceuticals

50 followers

BioMarin Pharmaceutical

29 followers

Ionis Pharmaceuticals

22 followers

BeiGene

18 followers

Discover companies